Important Milestone for European Phase III Trial Triggers 9-Month Follow-Up Period. Data Readout Expected in the Middle of 2016 MONT-SAINT-GUIBERT, Belgium, Celyad SA (Euronext Brussels, Euronext ...
– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Injections and infusions are a common way to receive chemotherapy. Both methods deliver cancer-treating medications directly into the bloodstream. Chemotherapy is a common cancer treatment that uses ...
Rheumatoid arthritis infusions deliver biologic medications directly into the bloodstream to slow the disease’s progression, particularly when oral medications aren’t sufficient. Different types of ...
If you have rheumatoid arthritis (RA), your doctor may suggest you get an infusion treatment -- medicine that goes into your body through a needle they place in a vein. One type of medication that you ...
Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on OCREVUS levels in the blood over 12 weeks OCREVUS subcutaneous injection was comparable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results